Jacob Strahilevitz

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Emergency Department

Acute Lymphoblastic Leukemia

Acinetobacter Baumannii

Multidrug Resistant

Top Venues

Microbial drug resistance (Larchmont, N.Y.)

International journal of health policy and management

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob Strahilevitz, Shaul Oreg, Ran Nir-Paz, Lilach Sagiv
Nurses' and Physicians' Responses to a New Active Antimicrobial Stewardship Program: A Two-Phase Study of Responses and Their Underlying Perceptions and Values. International journal of health policy and management (2022)
Tamir Zelter, Jacob Strahilevitz, Karina Simantov, Olga Yajuk, Yvonne Adams, Anja Ramstedt Jensen, Ron Dzikowski, Zvi Granot
Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria. EMBO reports 23 (6) (2022)
Amit Ginzburg, Gal Goldstein, Dror Raviv, Hodaya Cohen, Sigal Weinreb, Dan Harlev, Adi Nitsan-Luques, Mohammad Yacoub Abou Saoud, Jacob Strahilevitz, Diana Averbuch
Bacteremia in Children with Solid Tumors: Etiology, Antimicrobial Susceptibility, Factors Associated with Multidrug Resistance, and Mortality. Microbial drug resistance (Larchmont, N.Y.) 28 (5) (2022)
Ariel Kenig, Yonatan Oster, Ronit Cohen-Poradosu, Klaris Reisenberg, Anat Wieder-Finesod, Mirit Hershman-Sarafov, Ilana Oren, Gabriel Weber, Ron Dagan, Gili Regev-Yochay, Jacob Strahilevitz
Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (11) (2022)
Diana Averbuch, Liya Moshkovitz, Shlomi Ilan, Wiessam Abu Ahmad, Violeta Temper, Jacob Strahilevitz
Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria. Microbial drug resistance (Larchmont, N.Y.) 28 (5) (2022)